Androgenetic Alopecia in Men and Women

    March 2001 in “ Clinics in Dermatology
    Rodney Sinclair, Rodney P.R. Dawber
    From the encyclopedia
    Cyproterone →

    a synthetic anti-androgen and weak progestogen that inhibits DHT binding to androgen receptor

    Finasteride →

    Frontline, gold standard treatment for combatting androgenic alopecia

    Image
    Studysummary This article discusses treatment approaches for female pattern hair loss and concludes that available medical treatments are effective in reversing or stabilizing the condition in most cases of mild-to-moderate severity. Our plain-language summary of this paper — not a Tressless recommendation.
    This document from 22 years ago discusses androgenetic alopecia in both men and women. It covers topics such as the genetics and hormonal factors involved in hair loss, as well as the psychological effects of alopecia. The document includes references to various studies and research on the subject, including the prevalence of endocrine disorders and polycystic ovaries in patients with hirsutism or androgenic alopecia. It also discusses the differences in testosterone metabolism by beard and scalp hair follicle dermal papilla cells. Overall, the document provides a comprehensive overview of androgenetic alopecia and its various aspects. The document also discusses various treatments for androgenetic alopecia in men and women, including medications such as cyproterone acetate, flutamide, and finasteride, as well as scalp surgery. The article also mentions future developments in the field, such as second generation steroidal 5a reductase inhibitors and gene therapy.
    Discuss this study in the Community →

    Research cited in this study

    43 / 43 results